These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8171412)
1. Comparison of a platelet neutralization procedure with a hexagonal phase phospholipid neutralization assay as confirmatory tests for the presence of lupus anticoagulants. Reber G; Roisin JP; Migaud M; de Moerloose P Thromb Res; 1994 Jan; 73(2):131-5. PubMed ID: 8171412 [No Abstract] [Full Text] [Related]
2. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection]. Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068 [TBL] [Abstract][Full Text] [Related]
3. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Triplett DA; Barna LK; Unger GA Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436 [TBL] [Abstract][Full Text] [Related]
5. The association of lupus anticoagulant and anti-DNA binding in patients with systemic lupus erythematosus. Bennett RE; Calabrese LH; Lucas FV; Clough JD Cleve Clin Q; 1985; 52(2):115-8. PubMed ID: 3928199 [No Abstract] [Full Text] [Related]
6. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. Thiagarajan P; Shapiro SS; De Marco L J Clin Invest; 1980 Sep; 66(3):397-405. PubMed ID: 6772673 [TBL] [Abstract][Full Text] [Related]
7. Inosithin neutralization test to measure lupus anticoagulants. Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN Am J Clin Pathol; 1993 Jan; 99(1):61-4. PubMed ID: 8422019 [TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulants and antiphospholipid antibodies: comparison of clotting tests with an immunological assay. Aillaud MF; Reviron D; Alessi MC; Harle JR; Amiral J; Juhan-Vague I Thromb Res; 1990 Oct; 60(2):181-3. PubMed ID: 2126402 [No Abstract] [Full Text] [Related]
9. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times. Alving BM; Barr CF; Tang DB Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643 [TBL] [Abstract][Full Text] [Related]
11. Laboratory detection of antiphospholipid antibodies. Kandiah DA; Krilis SA Lupus; 1996 Apr; 5(2):160-2. PubMed ID: 8743133 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants. Devreese KM Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217 [No Abstract] [Full Text] [Related]
14. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients. Formiga F; Mitjavila F; Pac M; Moga I Lupus; 1997; 6(5):486. PubMed ID: 9229372 [No Abstract] [Full Text] [Related]
15. Lupus anticoagulant testing with optical end point automation. Luddington R; Scales C; Baglin T Thromb Res; 1999 Nov; 96(3):197-203. PubMed ID: 10588462 [TBL] [Abstract][Full Text] [Related]
16. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant. Forastiero RR; Falcón CR; Carreras LO Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955 [TBL] [Abstract][Full Text] [Related]
18. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Thiagarajan P; Pengo V; Shapiro SS Blood; 1986 Oct; 68(4):869-74. PubMed ID: 3092888 [TBL] [Abstract][Full Text] [Related]
19. Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo. Rauch J; Janoff AS Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4112-4. PubMed ID: 2112249 [TBL] [Abstract][Full Text] [Related]